cemka > Publications > 2019

Sort publications on year

  • Pharmaco - Epidemiology

    Toxigenic Clostridium difficile carriage in general practice: results of a laboratory-based cohort study

    BARBUT F, DAY N, BOUÉE S, YOUSSOUF A, GRANDVOINNET L, LALANDE V, COUTURIER J, ECKERT C

    Clin Microbiol Infect ; 2019;25(5):588-594

  • Biometry and database analysis

    Effectiveness of sequencing TKIs in patients with EGFR mutation-positive non-small cell lung cancer (NSCLC): A French national medical-administrative claim database analysis

    GIRARD N, BOUEE S, MORO-SIBILOT D, EMERY C, LE LAY K, LUCIANI L, MARITAZ C, CHOUAID C

    Annals of Oncology ; 2019;30(5):v627-v628

  • Public Health and Epidemiology

    Feedback on the transition to routine use of Connexin, a tool to improve city-hospital cooperation

    DUROCHER V, DUBURCQ A, PAMART R

    The European Journal of Public Health ; 2019;29(supp.4)

  • Public Health and Epidemiology

    Mapping of early intervention programs for psychosis in France in 2018

    COUROUVE L, DUBURCQ A, GOZLAN G, MEUNIER-CUSSAC S, LECARDEUR L, KREBS MO

    The European Journal of Public Health ; 2019;29(supp.4)

  • Pharmaco-Economics

    Prise de position de la Société Francophone du Diabète (SFD) sur la prise en charge médicamenteuse de l’hyperglycémie du patient diabétique de type 2

    DARMON P, BAUDUCEAU B, BORDIER L, CHARBONNEL B, COSSON E, DETOURNAY B, FONTAINE P, GRIMALDI A, GOURDY P, GUERCI B, HANAIRE H, PENFORNIS A, SCHEEN A

    Médecine des Maladies Métaboliques ; 2019;13(8):711-732

  • Pharmaco-Economics

    Prise de position de la Société Francophone du Diabète (SFD) : évaluation du rapport bénéfices-risques des inhibiteurs de SGLT2.

    BAUDUCEAU B, BORDIER L, BRINGER J, CHABRIER G, CHARBONNEL B, COSSON E, DARMON P, DETOURNAY B, FONTAINE P, GOURDY P, GRIMALDI A, GUERCI B, HANAIRE H, PENFORNIS A, RIVELINE J-P, SCHEEN A.

    Médecine des Maladies Métaboliques. ; 2019;13(2):195-209

  • Pharmaco-Economics

    Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims.

    DETOURNAY B, DEBOUVERIE M, PEREIRA O, SEYER D, SOUDAN M, COUROUVE L, JHOMA K, EPSTEIN J, GUILLEMIN F.

    Mult Scler Relat Disord ; 2019;36

  • Public Health and Epidemiology

    Expérimentation de la télé-expertise en cardiologie en Pays de la Loire.

    HERAULT T, DONIO V, COUROUVE L, CAILLARD J.-B.

    Santé publique ; 2019;31(6):789-796

  • Biometry and database analysis

    Profile of Women Initiated on Denosumab and Pattern of Use in a Restricted Postmenopausal Osteoporosis Indication: A French Database Analysis Over the Period 2013-2014.

    EMERY C, GOURMELEN J, FAGNANI F, SUZAN F, DESAMERICQ G, FARDELLONE P.

    Adv Ther ; 2019;36(4),969-975

  • Public Health and Epidemiology

    The management of emergency hospital visits for inflammatorybowel diseases: A French national expert consensus report.

    HEBUTERNE X, PEYRIN-BIROULET L, HAUSFATER P.

    Digestive and Liver Disease ; 2019

  • Pharmaco-Economics

    Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study

    HEQUET D, HUCHON C, SOILLY AL, ASSELAIN B, BERSENEFF H, TRICHOT C, COMBES A, ALVES K, NGUYEN T, ROUZIER R, BAFFERT S.

    PLoS One ; 2019;14(7)

  • Biometry and database analysis

    The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database

    BOURDIN A, FABRY-VENDRAND C, OSTINELLI J, AIT-YAHIA M, DARNAL E, BOUEE S, LAURENDEAU C, BUREAU I, GOURMELEN J, CHOUAID C.

    J Allergy Clin Immunol Pract ; 2019;7(5):1477-1487

  • Pharmaco - Epidemiology

    Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study

    DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.

    Eur J Clin Microbiol Infect Dis ; 2019

  • Biometry and database analysis

    Migraine burden and costs in france: a nationwide claims database analysis of triptan users.

    DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.

    J Med Econ ; 2019

  • Biometry and database analysis

    Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.

    LAFUMA A, COTTÉ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.

    J Med Econ ; 2019